Welcome to BusinessBankruptcies.com!

Sign up for a free account to get access to data on case creditors, search for cases, and more.

Aegerion Pharmaceuticals Holdings, Inc.

COURT
New York Southern Bankruptcy Court
CASE NUMBER
1:2019bk11633
TYPE / CHAPTER
Voluntary / 11

Case Information

This case has a LEAD CASE: Aegerion Pharmaceuticals, Inc.

When following such a bankruptcy, it is important to follow the lead case. When we detect a group of jointly administered cases, we mark the associated and lead cases. The case information tab of the case page will show whether a case is associated with a lead case, or is a lead case and has associated cases.

Filed

5-20-19

Updated

9-13-23

Last Checked

5-21-19

Assets

Subscribe

Liabilities

Subscribe

Get notified when your customers file for bankruptcy

Docket

Last Updated
May 21, 2019
Last Entry Filed
May 21, 2019

Docket Entries by Quarter

May 20, 2019 1 Petition Chapter 11 Voluntary Petition for Non-Individual. Order for Relief Entered. Filed by Paul V. Shalhoub of Willkie Farr & Gallagher LLP on behalf of Aegerion Pharmaceuticals Holdings, Inc.. (Shalhoub, Paul) (Entered: 05/20/2019)
May 20, 2019 Receipt of Voluntary Petition (Chapter 11)( 19-11633) [misc,824] (1717.00) Filing Fee. Receipt number A13218205. Fee amount 1717.00. (Re: Doc # 1) (U.S. Treasury) (Entered: 05/20/2019)
May 21, 2019 2 Declaration of John R. Castellano in Support of Chapter 11 Petitions and First Day Pleadings filed by Paul V. Shalhoub on behalf of Aegerion Pharmaceuticals Holdings, Inc.. (Shalhoub, Paul) (Entered: 05/21/2019)
May 21, 2019 3 Motion for Joint Administration filed by Paul V. Shalhoub on behalf of Aegerion Pharmaceuticals Holdings, Inc.. (Shalhoub, Paul) (Entered: 05/21/2019)
May 21, 2019 4 Schedules filed: Schedule A/B - Non-Individual, Schedule D - Non-Individual, Schedule E/F - Non-Individual, Schedule G - Non-Individual, Schedule H - Non-Individual Filed by Paul V. Shalhoub on behalf of Aegerion Pharmaceuticals Holdings, Inc.. (Shalhoub, Paul) (Entered: 05/21/2019)
May 21, 2019 5 Statement of Financial Affairs - Non-Individual Filed by Paul V. Shalhoub on behalf of Aegerion Pharmaceuticals Holdings, Inc.. (Shalhoub, Paul) (Entered: 05/21/2019)

This case is closed and is no longer being updated.

Case Information

Court
New York Southern Bankruptcy Court
Case number
1:2019bk11633
Assets
Subscribe for Access
Liabilities
Subscribe for Access
Judge
Chapter
11
Filed
May 20, 2019
Type
voluntary
Terminated
May 28, 2020
Updated
Sep 13, 2023
Last checked
May 21, 2019
Lead case
Aegerion Pharmaceuticals, Inc.

Associated Cases

    This case has no creditors listed.

    Parties

    Debtor

    Aegerion Pharmaceuticals Holdings, Inc.
    245 First Street, Riverview II
    18th Floor
    Cambridge, MA 02142
    MIDDLESEX-MA
    United States
    Tax ID / EIN: xx-xxx1331

    Represented By

    Paul V. Shalhoub
    Willkie Farr & Gallagher LLP
    787 Seventh Avenue
    New York, NY 10019-6099
    (212) 728-8764
    Fax : (212) 728-8111
    Email: maosbny@willkie.com

    U.S. Trustee

    United States Trustee
    Office of the United States Trustee
    U.S. Federal Office Building
    201 Varick Street, Room 1006
    New York, NY 10014
    (212) 510-0500

    Nearby Cases

    Date Filed Nameparent case = parent case Chapter Case #
    Jun 26, 2023 FirstSight Group LLC 7 1:2023bk11024
    Mar 21, 2023 Three Companies, LLC 7 1:2023bk10412
    Mar 2, 2023 Ralph T. Centanni, Trustee of the Frederick A. Cen 11 1:2023bk10317
    Feb 28, 2023 Cassandra AMG LLC 7 1:2023bk10292
    Feb 27, 2023 FirstSight B LLC 7 1:2023bk10284
    Aug 9, 2021 Impact Global Education, Inc. 7 1:2021bk11148
    Jul 15, 2019 New England Blazers, LLC 7 1:2019bk12394
    May 20, 2019 Aegerion Pharmaceuticals, Inc. 11 1:2019bk11632
    Nov 10, 2016 31 Tozer Road, LLC 11 1:16-bk-14309
    Jan 30, 2015 Pathways To Wellness, Inc. 7 1:15-bk-10349
    Oct 24, 2014 Vesy, Inc. 7 1:14-bk-14985
    Nov 15, 2012 Helicos Biosciences Corporation 11 1:12-bk-19091
    Nov 7, 2012 TMC Investors, LLC 11 1:12-bk-13045
    Nov 7, 2012 Monitor Company Group Limited Partnership 11 1:12-bk-13042
    Oct 30, 2012 Inspiration Biopharmaceuticals, Inc. 11 1:12-bk-18687